Heterotrimeric G-protein subunit Gαi2 contributes to agonist-sensitive apoptosis and degranulation in murine platelets by Cao, Hang et al.
ORIGINAL RESEARCH
Heterotrimeric G-protein subunit Gai2 contributes to
agonist-sensitive apoptosis and degranulation in murine
platelets
Hang Cao1, Syed M. Qadri2,3, Elisabeth Lang4, Lisann Pelzl1, Anja T. Umbach1, Veronika Leiss5,
Lutz Birnbaumer6,7, Bernd N€urnberg5, Burkert Pieske8,9,10, Jakob Voelkl8,9,10, Meinrad Gawaz11,
Rosi Bissinger11,a & Florian Lang1,4,a
1 Department of Vegetative & Clinical Physiology, Eberhard-Karls University, T€ubingen, Germany
2 Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
3 Centre for Innovation, Canadian Blood Services, Hamilton, Ontario, Canada
4 Department of Molecular Medicine II, Heinrich Heine University, D€usseldorf, Germany
5 Department of Pharmacology and Experimental Therapy, Interfaculty Center of Pharmacology and Drug Research (ICePhA), Eberhard-Karls
University, T€ubingen, Germany
6 Neurobiology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, North Carolina
7 Institute of Biomedical Research (BIOMED), Catholic University of Argentina, Buenos Aires, Argentina
8 Department of Internal Medicine and Cardiology, Charite-Universit€atsmedizin Berlin, and German Heart Institute, Berlin, Germany
9 Berlin Institute of Health (BIH), Berlin, Germany
10 DZHK (German Centre for Cardiovascular Research), partner site, Berlin, Germany
11 Department of Internal Medicine III, Eberhard-Karls University, T€ubingen, Germany
Keywords
Apoptosis, degranulation, G-protein, Gai2,
platelets.
Correspondence
Rosi Bissinger, Department of Internal
Medicine III, University hospital T€ubingen,
Otfried-M€uller-Straße 10, D72076 Tuebingen,
Germany.
Tel: +49 7071/29 76890
Fax: +49 7071 29 5749
E-mail: rosi.bissinger@uni-tuebingen.de
Funding Information
This study was supported by Deutsche
Forschungsgemeinschaft (Nr. La 315/15-1)
and by the European Union Seventh
Framework Programme (FP7/2007-2013),
Systems Biology to Identify Molecular Targets
for Vascular Disease Treatment (SysVasc,
HEALTH-2013 603288). Work of RB is
supported by the Institutional Strategy of the
University of Tuebingen (Deutsche
Forschungsgemeinschaft, ZUK63). This work
was in part funded by the Deutsche
Forschungsgemeinschaft (NU 53/9 and NU
53/13-1 to BN). LB was supported by
Intramural Research Program of the NIH
(project Z01-ES-101643).
Received: 22 July 2018; Accepted: 27 July
2018
Abstract
Gai2, a heterotrimeric G-protein subunit, regulates various cell functions
including ion channel activity, cell differentiation, proliferation and apoptosis.
Platelet-expressed Gai2 is decisive for the extent of tissue injury following
ischemia/reperfusion. However, it is not known whether Gai2 plays a role in
the regulation of platelet apoptosis, which is characterized by caspase activa-
tion, cell shrinkage and cell membrane scrambling with phosphatidylserine
(PS) translocation to the platelet surface. Stimulators of platelet apoptosis
include thrombin and collagen-related peptide (CoRP), which are further
known to enhance degranulation and activation of aIIbb3-integrin and cas-
pases. Using FACS analysis, we examined the impact of agonist treatment on
activation and apoptosis in platelets drawn from mice lacking Gai2 and their
wild-type (WT) littermates. As a result, treatment with either thrombin
(0.01 U/mL) or CoRP (2 lg/mL or 5 lg/mL) significantly upregulated PS-
exposure and significantly decreased forward scatter, reflecting cell size, in
both genotypes. Exposure to CoRP triggered a significant increase in active
caspase 3, ceramide formation, surface P-selectin, and aIIbb3-integrin
activation. These molecular alterations were significantly less pronounced in
Gai2-deficient platelets as compared to WT platelets. In conclusion, our data
highlight a previously unreported role of Gai2 signaling in governing platelet
activation and apoptosis.
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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Introduction
Heterotrimeric G proteins are coupled to plasma mem-
brane receptors and participate in the regulation of a
wide range of cellular functions such as migration, differ-
entiation, proliferation, ion channel activity, and apopto-
sis (Hilger et al. 2018; Squires et al. 2018). In platelets,
fundamental elements of the hemostasis machinery, a
wide array of cell surface receptors coupled to G proteins
mediate their activation (Offermanns 2006). The P2Y12
receptor, an important therapeutic target contributing to
purinergic stimulation of platelets, is coupled to heterotri-
meric Gai2 protein, the predominant Ga isoform (Gachet
2012). More recently, Gai2 protein was reported to play a
thrombo-inflammatory role in orchestrating thrombus
stabilization during hemostasis and mediating tissue dam-
age during experimental cerebral and myocardial ische-
mia-reperfusion injury (Devanathan et al. 2015).
Platelets are activated by a wide range of agonists such
as subendothelial collagen, thrombin, ADP secreted from
stimulated platelets, and by collagen-related peptide
(CoRP) (Lang et al. 2013). In the presence of stimulatory
signals, platelets degranulate, undergo phospholipid
scrambling on their cell membrane, and aggregate to form
thrombi that results in vascular blockage (Varga-Szabo
et al. 2009; Munzer et al. 2014). Cell membrane scram-
bling with phosphatidylserine (PS) exposure fosters the
assembly of tenase and prothrombinase complexes, and
subsequently promoting factor Xa and thrombin genera-
tion (Lebois and Josefsson 2016). In platelets, uncon-
strained apoptosis has been implicated in
thrombocytopenia, bleeding disorders, microparticle shed-
ding as well as affecting their quality during storage
(Lebois and Josefsson 2016; Quach et al. 2018). PS expo-
sure in apoptotic platelets, triggered by exogenous agents
or physiological changes, leads to their clearance from the
circulation (Lebois and Josefsson 2016; Quach et al.
2018). Gai2 has previously been shown to participate in
the apoptosis machinery of different cell types (Lopez-
Aranda et al. 2008; Bissinger et al. 2016). Despite the
recent evidence linking Gai2 protein to the execution of
thrombosis, its role in platelet survival has hitherto
remained elusive. In the present study, using thrombin
and collagen-related peptide (CoRP), an agonist mimick-
ing the effect of contact with collagen and a powerful
stimulator of platelet apoptosis (Munzer et al. 2018), we
investigated the influence of Gai2 on platelet survival and
degranulation ex vivo.
Materials and Methods
Mice
Experiments were performed in Gai2-deficient mice (Gai2
/)
and their wild-type (WT) littermates of 10–12 weeks of
age. The mice were generated and initially characterized on
a SV129 background (Rudolph et al. 1995). Mice were
backcrossed on a C57BL/6 background and kept under
specified pathogen-free (SPF) environment in individually
ventilated cages (IVC) to prolong life expectancy (Wiege
et al. 2013; Devanathan et al. 2015). All animal experi-
ments were conducted according to the German law for the
care and use of laboratory animals and were approved by
local government authorities (Regierungspr€asidium T€ubin-
gen according to §4 of 19/12/2011).
Preparation of mouse platelets
Platelets were obtained from 10- to 12-week-old mice of
either sex which were treated according to the protocol
approved by government authorities. Eight hundred ll
blood was obtained into tubes containing 200 ll acid-
citrate-dextrose buffer. Platelet rich plasma (PRP) was
obtained by centrifugation at 260 g for 5 min. PRP was
then centrifuged at 640 g for 5 min to pellet the platelets.
Where necessary, apyrase (0.02 U/mL; Sigma-Aldrich) and
prostaglandin I2 (0.5 lmol/L; Calbiochem) were added to
the PRP to prevent activation of platelets during isolation.
After two washing steps, the pellet of washed platelets was
resuspended in modified Tyrode-HEPES buffer (pH 7.4,
supplemented with 1 mmol/L CaCl2). Where indicated,
thrombin (0.01 U/mL, Roche, Basel, Switzerland) or colla-
gen-related peptide (CoRP, 2 lg/mL or 5 lg/mL, kindly
provided by R. Farndale, University of Cambridge, Cam-
bridge, UK) were added (Liu et al. 2016).
Cytosolic calcium
For the measurement of the cytosolic Ca2+ concentration,
the platelet preparation was washed once in Tyrode buffer
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(pH 7.4), stained with 3 lmol/L Fluo-3AM (Biotium,
USA) in the same buffer and incubated at 37°C for
30 min. Following the indicated experimental treatment,
relative fluorescence was measured utilizing a BD FACS
Calibur (BD Biosciences, Heidelberg, Germany) (Towhid
et al. 2011; Liu et al. 2016).
P-selectin and activated integrin abundance
Fluorophore-labeled antibodies were utilized for the detec-
tion of P-selectin expression (Wug.E9-FITC, Emfret Analyt-
ics, Eibelstadt, Germany) and the active form of aIIbb3
integrin (JON/A-PE, Emfret Analytics, Eibelstadt, Germany).
Washed mouse platelets (1x106) were suspended in modified
Tyrode buffer (pH 7.4) containing 1 mmol/L CaCl2 and
antibodies (1:10 dilution) and subsequently subjected to the
respective treatments and for the indicated time periods at
room temperature (RT). The reaction was stopped by addi-
tion of PBS and the samples were immediately analyzed by
FACS analysis (Liu et al. 2015).
Phosphatidylserine exposure and forward
scatter
Phosphatidylserine exposure was determined in platelets
with and without a 10 min thrombin or CoRP treatment
(Liu et al. 2016). To this end, the platelet preparation was
centrifuged at 660 g for 5 min followed by washing once
with Tyrode buffer (pH 7.4) with 1 mmol/L CaCl2, stain-
ing with 1:20 dilution of Annexin-V FITC (ImmunoTools,
Germany) in Tyrode buffer (pH 7.4) in the presence of
2 mmol/L CaCl2 and incubation at 37°C for 30 min.
Annexin-V binding reflecting surface exposure of phos-
phatidylserine was evaluated by FACS analysis. In parallel,
Table 1. Analyzed parameters in WT and Gai2-deficient mice
A: Annexin-V-binding and forward scatter in WT female and male mice
Parameter
WT (female) WT (male)
Resting Thrombin CoRP Resting Thrombin CoRP
Annexin-V-binding [%] 0.89  0.02 17.07  2.50 19.22  0.87 1.06  0.39 18.22  2.34 18.60  2.75
Forward Scatter [Geomean; arb. units] 14.95  1.00 10.43  0.95 8.15  0.18 15.09  0.46 11.29  1.03 9.42  1.11
B: Annexin-V-binding and forward scatter in Gai2-deficient female and Gai2-deficient male mice
Parameter
Gai2-deficient (female) Gai2-deficient (male)
Resting Thrombin CoRP Resting Thrombin CoRP
Annexin-V-binding [%] 1.13  0.17 13.65  0.66 8.75  2.84 1.26  0.53 14.11  0.99 10.32  0.98
Forward Scatter [Geomean; arb. units] 15.94  0.53 12.04  0.87 11.10  0.86 16.68  0.58 13.30  0.55 11.97  0.46
C: P-selectin, activated integrin aIIbb3, caspase-3-positive cells and ceramide abundance in WT female and WT male mice
Parameter
WT (female) WT (male)
Resting CoRP Resting CoRP
P-selectin [MFI] 5.29  0.43 28.01  5.63 5.74  0.39 31.86  3.10
Activated integrin aIIbb3 [MFI] 5.59  0.27 96.61  15.64 5.29  0.50 88.90  0.83
Caspase-3-positive cells [%] 4.65  0.60 21.91  1.65 4.28  0.23 22.69  2.16
Ceramide abundance [MFI] 19.38  2.28 25.48  0.28 21.09  0.08 24.91  3.47
D: P-selectin, activated integrin aIIbb3, caspase-3-positive cells and ceramide abundance in Gai2-deficient female and Gai2-deficient male mice
Parameter
Gai2-deficient (female) Gai2-deficient (male)
Resting CoRP Resting CoRP
P-selectin [MFI] 5.28  0.34 22.98  4.65 5.04  0.23 23.34  7.23
Activated integrin aIIbb [MFI] 5.30  0.13 59.79  16.38 5.44  0.44 44.88  13.68
Caspase-3-positive cells [%] 4.10  0.13 8.75  1.52 3.95  0.34 9.43  0.80
Ceramide abundance [MFI] 19.25  1.44 20.13  2.33 20.54  2.43 20.13  2.02
Annexin-V-binding, forward scatter, P-selectin abundance, activated integrin aIIbb3, caspase-3-positive cells, and ceramide abundance in female
and male WT and Gai2-deficient mice after thrombin and/or CoRP stimulation.
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the forward scatter (FSC) of the platelets was determined
by FACS analysis, as a measure of platelet size (Liu et al.
2016).
Caspase-3 activity
Caspase 3 activity was determined utilizing a CaspGlow
Fluorescein Active Caspase-3 Staining kit from BioVision
(CA, USA) according to the manufacturer’s instruction.
Fluorescence intensity was measured at an excitation
wavelength of 488 nm and an emission wavelength of 530
by FACS analysis.
Ceramide abundance
Ceramide abundance at platelet cell surface was measured
by a monoclonal antibody-assay. For this purpose, plate-
lets were stained at 37°C for 1 h at a concentration of
1 lg/mL anti-ceramide antibody (clone MID 15B4, Enzo
Life Science GmbH, L€orrach, Germany) in Tyrode buffer
at a dilution of 1:10. Platelets were washed once with Tyr-
ode buffer. Subsequently, platelets were stained for
30 min with polyclonal fluorescein isothiocyanate (FITC)
conjugated goat anti-mouse IgG and IgM specific anti-
body (BD Pharmingen, Hamburg, Germany) at a concen-
tration of 1:50 in Tyrode buffer. Washing of the platelets
was performed in order to remove unbound secondary
antibody. Finally, the samples were analyzed by flow
cytometry at an excitation wavelength of 488 nm and an
emission wavelength of 530 nm, as has previously been
shown (Gatidis et al. 2010).
Statistical analysis
Data are shown as means  SD; n represents the number
of independent experiments. All data were tested for
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Figure 1. Gai2 participates in the regulation of platelet cell membrane scrambling and platelet volume. (A–C) Original histogram overlays of
the annexin-V binding in platelets isolated from WT mice (blue shadow) and Gai2-deficient mice (black line) without (A) and with (B) a 10 min
treatment with thrombin (0.01 U/mL) or (C) a 10 min treatment with collagen-related peptide CoRP (5 lg/mL). (D) Arithmetic means  SD
(n = 4) of the annexin-V binding in platelets isolated from WT mice (blue bar) and Gai2-deficient mice (black bar) prior to (control) and
following a 10 min treatment with thrombin (0.01 U/mL) or a 10 min treatment with collagen-related peptide CoRP (5 lg/mL). ### (P < 0.001)
indicates statistically significant difference from absence of thrombin and CoRP, * (P < 0.05) and *** (P < 0.001) indicates statistically
significant difference from WT mice. (E–G) Original histogram overlays of the forward scatter of platelets isolated from WT mice (blue shadow)
and Gai2-deficient mice (black line) without (E) and with (F) a 10 min treatment with thrombin (0.01 U/mL) or (G) a 10 min treatment with
collagen-related peptide CoRP (5 lg/mL). (H) Arithmetic means  SD (n = 4) of the forward scatter of platelets isolated from WT mice (blue
bar) and Gai2-deficient mice (black bar) prior to (control) and following a 10 min treatment with thrombin (0.01 U/mL) or a 10 min treatment
with collagen-related peptide CoRP (5 lg/mL). ### (P < 0.001) indicates statistically significant difference from absence of thrombin and CoRP,
* (P < 0.05) and *** (P < 0.001) indicates statistically significant difference from WT mice.
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significance using ANOVA. P < 0.05 was considered sta-
tistically significant.
Results
This study addressed the impact of Gai2 on activation
and apoptosis of murine platelets. For this purpose,
experiments were performed in mice lacking Gai2 and
corresponding wild type mice. The platelets were analyzed
with or without prior exposure to thrombin (0.01 U/mL)
or collagen-related peptide (CoRP, 2 lg/mL and 5 lg/
mL). Individual values (mean  SD) of female and male
WT and Gai2-deficient mice of annexin-V-binding, plate-
let volume, caspase-3-positive cells, ceramide abundance,
P-selectin abundance and activated integrin aIIbb3 are dis-
played in Table 1A–D. No significant differences were
observed between male and female WT or Gai2-deficient
mice.
Phosphatidylserine exposure, a hallmark of platelet
apoptosis, was quantified by flow cytometry analysis
using annexin-V-binding as described previously (Cao
et al. 2017). As illustrated in Figure 1A and D, the
percentage of PS-positive platelets in untreated resting
Gai2
/ and WT platelets was not significantly
different. Treatment with thrombin and CoRP signifi-
cantly enhanced the percentage of PS-positive plate-
lets, an effect significantly less pronounced in Gai2
/
platelets as compared to WT platelets (Fig. 1B–D).
Next, we explored whether Gai2-mediated platelet
apoptosis accompanies cell volume alterations (Cao
et al. 2017). As depicted in Figure 1E and H, forward
scatter, reflecting platelet volume, was not significantly
different in resting platelets of either genotype but
was significantly reduced following thrombin and
CoRP treatment, an effect significantly less pro-
nounced in Gai2
/ platelets than in WT platelets
(Fig. 1F–H).
We then sought to elucidate the mechanism(s) regu-
lating Gai2-mediated apoptosis. To this end, we analyzed
intracellular Ca2+ levels [Ca2+]i in murine platelets of
either genotype using Fluo3 AM fluorescence as
described previously (Cao et al. 2017). As a result, prior
to CoRP treatment, [Ca2+]i in resting platelets was simi-
lar in Gai2
/ platelets (22.73  0.69, a.u.; n = 10) and
in WT platelets (20.95  0.50, a.u.; n = 10). Treatment
with CoRP was followed by a profound and significant
increase of [Ca2+]i in both Gai2
/ (109.3  1.46, a.u.,
n = 10) and WT platelets (105.9  0.69, a.u.; n = 10).
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Figure 2. Gai2 participates in the regulation of platelet caspase 3 activation and ceramide formation. (A and B) Original histogram overlays of
the caspase 3 activity in platelets isolated from WT mice (blue shadow) and Gai2-deficient mice (black line) without (A) and with (B) a 10 min
treatment with collagen-related peptide CoRP (5 lg/mL). (C) Arithmetic means  SD (n = 6) of the caspase 3 activity (arbitrary units) in
platelets isolated from WT mice (blue bar) and Gai2-deficient mice (black bar) prior to (control) and following a 10 min treatment with
collagen-related peptide CoRP (5 lg/mL). ### (P < 0.001) indicates statistically significant difference from absence of CoRP, *** (P < 0.001)
indicates statistically significant difference from WT mice. (D and E) Original histogram overlays of the ceramide abundance of platelets isolated
from WT mice (blue shadow) and Gai2-deficient mice (black line) without (D) and with (E) a 10 min treatment with collagen-related peptide
CoRP (5 lg/mL). (F) Arithmetic means  SD (n = 4) of the ceramide abundance of platelets isolated from WT mice (blue bar) and Gai2-deficient
mice (black bar) prior to (control) and following a 10 min treatment with collagen-related peptide CoRP (5 lg/mL). ## (P < 0.01) indicates
statistically significant difference from absence of CoRP, ** (P < 0.01) indicates statistically significant difference from WT mice.
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The increase following CoRP treatment was, however,
not significantly different between the two genotypes,
thus, ruling out the involvement of Ca2+ signaling in
Gai2-mediated platelet apoptosis.
Next, we explored whether other putative mechanisms
underpin the regulation of Gai2-mediated platelet apopto-
sis. To this end, caspase 3 fluorescence (Cao et al. 2017)
was measured and was similar in resting platelets of either
genotype (Fig. 2A and C), but was significantly upregu-
lated after CoRP treatment, an effect which was signifi-
cantly blunted in Gai2
/ platelets as compared to WT
platelets (Fig. 2B and C).
As has previously been shown, hyperosmotic shock
triggered a significant increase in platelet annexin-V-bind-
ing, an effect probably involving ceramide formation
(Gatidis et al. 2010). We thus examined whether ceramide
formation is altered in Gai2-deficient platelets as com-
pared to WT platelets. As illustrated in Figure 2D and F,
ceramide abundance was similar in resting platelets. CoRP
treatment elicited a significant increase in ceramide abun-
dance in WT platelets as compared to Gai2
/ platelets
(Fig. 2E and F), pointing to the involvement of sphin-
gomyelinase activation in the triggering of Gai2-mediated
platelet apoptosis.
We then tested whether Gai2 similarly mediates platelet
degranulation in response to CoRP. To this end, P-selectin
expression was similar in untreated resting and Gai2
/
platelets (Fig. 3A and C). Exposure to CoRP significantly
increased P-selectin expression (Cao et al. 2017) on the
platelet surface reflecting enhanced degranulation; this
effect was significantly reduced in Gai2
/ platelets as com-
pared to WT platelets (Fig. 3B and C). Next, we explored
whether active integrin aIIbb3 is different in the two
genotypes. As a result, active integrin aIIbb3 was similar
in WT and Gai2
/ platelets (Fig. 3D and F). In addition,
CoRP treatment further stimulated active integrin aIIbb3
(Cao et al. 2017) at the platelet surface, an effect that was
again significantly attenuated in Gai2
/ platelets (Fig. 3E
and F). Thus, Gai2 is dichotomously involved in both
platelet degranulation and apoptosis following agonist
exposure.
Discussion
Previous studies have shown that the effect of CoRP on
degranulation, PS exposure, cell volume, and aIIbb3 inte-
grin abundance is mediated, at least in part, by increased
[Ca2+]i (Varga-Szabo et al. 2009; Lang et al. 2013), which
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Figure 3. Gai2 participates in the regulation of platelet degranulation and integrin aIIbb3 activation. (A and B) Original histogram overlays of
P-selectin-related fluorescence reflecting degranulation in platelets isolated from WT mice (blue shadow) and Gai2-deficient mice (black line)
without (A) and with (B) a 15 min treatment with collagen-related peptide CoRP (2 lg/mL). (C) Arithmetic means  SD (n = 6) of the P-
selectin-related fluorescence (arbitrary units) in platelets isolated from WT mice (blue bar) and Gai2-deficient mice (black bar) prior to (control)
and following a 15 min treatment with collagen-related peptide CoRP (2 lg/mL). ### (P < 0.001) indicates statistically significant difference
from absence of CoRP, * (P < 0.05) indicates statistically significant difference from WT mice. (D and E) Original histogram overlays of the
aIIbb3 integrin-related fluorescence in platelets isolated from WT mice (blue shadow) and Gai2-deficient mice (black line) without (D) and with
(E) a 15 min treatment with collagen-related peptide CoRP (2 lg/mL). (F) Arithmetic means  SD (n = 6) of the aIIbb3 integrin-related
fluorescence (arbitrary units) in platelets isolated from WT mice (blue bar) and Gai2-deficient mice (black bar) prior to (control) and following a
15 min treatment with collagen-related peptide CoRP (2 lg/mL). ### (P < 0.001) indicates statistically significant difference from absence of
CoRP, *** (P < 0.001) indicates statistically significant difference from WT mice.
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is known to trigger platelet activation and stimulate arterial
thrombosis (Lang et al. 2013). Surprisingly, elevation of
[Ca2+]i was similar in platelets of either genotype suggest-
ing that Gai2 modifies platelet activation and apoptosis by
interfering with mechanisms other than Ca2+ entry.
Acid sphingomyelinase degrades membrane sphin-
gomyelin and generates ceramide, which is responsible for
cell membrane scrambling and degranulation in a variety
of cell types; this lipid signaling is vital in the pathophysi-
ology of several cardiovascular diseases (Lang et al. 2015).
Remarkably, both genetic deficiency and pharmacological
inhibition of acid sphingomyelinase has been shown to
thwart platelet secretion and PS exposure independently
of Ca2+ signaling, purportedly due to a signaling defect
downstream of phospholipase C activation (Munzer et al.
2014). Ceramide metabolism further involves ceramidases
which has been reported to ameliorate CoRP-triggered
glycoprotein VI-dependent platelet aggregation and
thrombus formation (Munzer et al. 2018). Along these
lines, it is tempting to speculate that PS-exposure and
degranulation of platelets mediated by Gai2-sensitive cera-
mide generation is a possible mechanism linking previous
observations of tissue injury and thrombosis after experi-
mental ischemia-reperfusion.
In conclusion, the present study sheds light on a novel
function of Gai2 protein, that is, the regulation of platelet
apoptosis, a process, at least in part, mediated by agonist-
sensitive ceramide formation. Our observations on Gai2-
mediated platelet survival may have pathophysiological
implications in thrombo-inflammatory conditions. Further
investigations are warranted to dissect the relevance of this
mechanism in platelet-related disorders in humans.
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